Skip to content

Probiotics for infant colic

The efficacy of 3 weeks supplementation with a probiotic dietary supplement on infant colic: a randomized, double-blind, placebo-controlled, parallel group study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN13340073
Enrollment
224
Registered
2017-08-24
Start date
2016-05-01
Completion date
Unknown
Last updated
2017-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infant colic Neonatal Diseases

Interventions

Prior to the start of the study, the allocation of subject numbers to study groups will be performed by randomization. Randomization will be stratified by infant age (=6 weeks versus >6 weeks). The ra

Sponsors

Chr. Hansen A/S
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Infant colic defined as crying or fussing episodes lasting more than 3 hours per day and occurring at least 3 days per week within 7 days prior to enrollment (ROME III) 2. Exclusive breast fed infants at inclusion 3. Less than 3 months of age 4. Greater than 37 weeks gestation at birth 5. Birth weight of more than 2500 g

Exclusion criteria

Exclusion criteria: 1. Formula fed or combination breast fed/ formula fed infants 2. Failure to thrive (weight gain < 100 grams/week averaged from birth to the last recorded weight) 3. Major medical problems (e.g. ill, immunocompromised, major developmental or genetic abnormality 4. Gastrointestinal disorder 5. Taking antibiotics four weeks prior to enrollment 6. Using probiotics in the past two weeks prior to enrollment 7. Taking antibiotics during intervention

Design outcomes

Primary

MeasureTime frame
Percentage of infants achieving a reduction in the daily crying/fussing time after 3 weeks treatment. Measured daily in diary. Baseline will be the mean of crying and fussing time measured daily in the diary during run in (day -7 to -1).

Secondary

MeasureTime frame
1. Stool frequency and consistency, measured daily in diary using Amsterdam Stool Form. Baseline will be the mean frequency and consistency measured daily in the diary during run in (day -7 to -1) 2. Faecal IgA and calprotectin, measured at baseline (before intervention, day -1) and end of intervention (day 21)

Countries

China

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026